CIK 0001104506 · Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- EIN
- 541972729
- Phone
- 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,737,650
- in 2 filings
Net −$3,737,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | Lewis William Chair and CEO | Sale 10b5-1 | −7,975 | $106.97 | $853K | 273,037 |
| 2026-05-18 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −6,259 | 25,037 | ||
| 2026-05-18 | Lewis William Chair and CEO | Option exercise · Stock Option (right to buy) 10b5-1 | −4,440 | 17,760 | ||
| 2026-05-14 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −10,479 | $117.54 | $1.2M | 64,910 |
| 2026-05-13 | Smith Michael Alexander Chief Legal Officer | Sale | −4,109 | $116.18 | $477K | 47,762 |
| 2026-05-13 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −4,470 | $112.76 | $504K | 78,773 |
| 2026-05-13 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −3,384 | $116.18 | $393K | 75,389 |
| 2026-05-13 | Desjardins Clarissa Director | Grant or award | +3,305 | 70,312 | ||
| 2026-05-13 | ANDERSON ELIZABETH M Director | Grant or award | +3,305 | 62,034 | ||
| 2026-05-13 | LEE LEO Director | Grant or award | +3,305 | 57,971 | ||
| 2026-05-13 | Adsett Roger Chief Operating Officer | Sale | −5,837 | $116.18 | $678K | 100,973 |
| 2026-05-13 | Brennan David R Director | Grant or award | +3,305 | 64,238 | ||
| 2026-05-13 | Bonstein Sara Chief Financial Officer | Sale | −8,272 | $116.18 | $961K | 71,486 |
| 2026-05-13 | Lewis William Chair and CEO | Sale | −13,283 | $116.18 | $1.5M | 287,902 |
| 2026-05-13 | SCHAFER CAROL Director | Grant or award | +3,305 | 66,622 | ||
| 2026-05-13 | SHAROKY MELVIN MD Director | Grant or award | +3,305 | 246,081 | ||
| 2026-05-11 | Flammer Martina M.D. Chief Medical Officer | Option exercise 10b5-1 | +12,949 | $17.07 | $221K | 96,192 |
| 2026-05-11 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −12,119 | $100.35 | $1.2M | 84,073 |
| 2026-05-11 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −830 | $101.18 | $84K | 83,243 |
| 2026-05-11 | Flammer Martina M.D. Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −12,949 | 0 |
Page 4 of 23 · 448 trades